Karolyn Oetjen

Medicine & Life Sciences

1. Acute Myeloid Leukemia 100%
2. Hematopoiesis 66%
3. Apoptosis 63%
4. Proteogenomics 43%
5. Fusariosis 42%
6. Decitabine 40%
7. Bone Marrow 40%
8. Caspase Activation and Recruitment Domain 38%
9. Ligands 37%
10. pembrolizumab 36%
11. T-Lymphocytes 34%
12. Toll-Like Receptor 1 34%
13. X-Linked Inhibitor of Apoptosis Protein 34%
14. Hematopoietic Stem Cells 33%
15. Bone Marrow Cells 32%
16. Primary Myelofibrosis 32%
17. Dendritic Cells 32%
18. Acute Promyelocytic Leukemia 32%
19. RNA Sequence Analysis 31%
20. Lymphoproliferative Disorders 30%
21. Lung Transplantation 30%
22. Homologous Transplantation 29%
23. Ubiquitin 29%
24. Ligases 28%
25. Hematology 28%
26. T-Lymphocyte Subsets 27%
27. Tumor Necrosis Factor Receptor-Associated Peptides and Proteins 27%
28. Neutropenia 26%
29. Interleukin-1 26%
30. Neoplasms 25%
31. Flow Cytometry 25%
32. Noise 24%
33. Transgenic Mice 23%
34. Toll-Like Receptor 2 23%
35. DNA Damage 22%
36. Prostate 21%
37. AEG 40730 21%
38. Prostatic Neoplasms 20%
39. Adenocarcinoma 20%
40. Mesenchymal Stem Cells 20%
41. Consolidation Chemotherapy 19%
42. Baculoviral IAP Repeat-Containing 3 Protein 18%
43. Allogeneic Cells 18%
44. Genes 17%
45. Fusarium 17%
46. Infections 16%
47. Natural Killer Cells 15%
48. Induction Chemotherapy 15%
49. Drug Therapy 15%
50. Therapeutics 15%